# A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants

> **NCT06006702** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Tyra Biosciences, Inc** · enrollment: 60 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TYRA-300-B01

## Key facts

- **NCT ID:** NCT06006702
- **Lead sponsor:** Tyra Biosciences, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-16
- **Primary completion:** 2025-05
- **Final completion:** 2025-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06006702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06006702, "A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06006702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*